Dr. Neil Solomons is Chief Medical Officer and Co-Founder of Aurinia Pharmaceuticals, a clinical stage biopharmaceutical company focused on developing and commercializing therapies in disease areas of high unmet medical need. Neil is working to develop a drug to treat a rare autoimmune disease called lupus nephritis. In lupus nephritis, there is inflammation of the kidneys that can result in kidney failure, need for dialysis, or kidney transplant. Currently, there are no FDA-approved therapies for this disease, and the team at Aurinia is excited to be in the final stages of developing a drug called Voclosporin to treat lupus nephritis. Outside of research, Neil is an obsessive soccer fan, and he has been avidly watching English Premier League games since he was a child. He also enjoys playing the guitar and spending time with his family. Neil was awarded his Medical Degree from the University of London’s Guys Hospital Medical School. Afterwards, he worked as a physician in London and completed specialist training in anesthesia and intensive care. Neil held positions at Roche Pharmaceuticals, Aspreva Pharmaceuticals, and Vifor Pharma before co-founding Aurinia. In our interview Neil will tell us more about his life and science.